ARCHIVES

NCI Anticipates 60% Decline In Number Of New Trials By Cooperative Groups.

This article is from The Cancer Letter archive.

Vol. 33 No. 01 | January 12, 2007

Download PDF Visit The Full Archive

Related Articles

FDA Oncology Division To Develop Papers On Expectations for New Drugs

August 2, 1996

Mass. Law Requires Reimbursement For Off-Label Cancer Drugs

January 22, 1993

In Brief: Mass. Selects Hoh As Health Commissioner; Komen Foundation Selects Research Fellows

August 8, 1997

ODAC Votes For Accelerated Approval For Adcetris For Two Lymphoma Indications

July 22, 2011

Facilities Survey: $2.5 Billion Will Be Required From 1986-1990, With NCI’s Share At $678 Million

April 12, 1985

NCAB Opposes Line Item for Centers

May 23, 1980